Tangled in bankruptcy proceedings and legal tussle, Sorrento secures $75M to stay afloat
Sorrento Therapeutics can keep the lights on for now.
Days after filing its Chapter 11 paperwork, the San Diego-based biotech said a bankruptcy court in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
